Epigenetic profiling joins personalized cancer medicine.

@article{Heyn2013EpigeneticPJ,
  title={Epigenetic profiling joins personalized cancer medicine.},
  author={Holger Heyn and Jes{\'u}s M{\'e}ndez-Gonz{\'a}lez and Manel Esteller},
  journal={Expert review of molecular diagnostics},
  year={2013},
  volume={13 5},
  pages={473-9}
}
Personalized medicine is defined by therapy decisions tailored to individual patients, aiming to improve therapeutic efficiencies and to minimize side effects. The current clinical practice includes targeted therapies for disease-related alterations and molecular biomarker-based patient stratification. However, recent advances in screening technologies have enabled more comprehensive identification strategies and suggest a plethora of additional valuable biomarkers and druggable molecules for… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS